Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
36738 | 74 | 29.5 | 72% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
351 | 3 | GAP JUNCTION//CONNEXIN//OLIGODENDROCYTE | 35607 |
1822 | 2 | GAP JUNCTION//CONNEXIN//CONNEXIN43 | 6209 |
36738 | 1 | IRSOGLADINE MALEATE//IRSOGLADINE//PERIODONTAL MED | 74 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | IRSOGLADINE MALEATE | authKW | 5420638 | 23% | 77% | 17 |
2 | IRSOGLADINE | authKW | 2475854 | 16% | 50% | 12 |
3 | PERIODONTAL MED | address | 565249 | 14% | 14% | 10 |
4 | GINGIVAL EPITHELIAL CELLS | authKW | 432924 | 11% | 13% | 8 |
5 | 6 2 5 DICHLOROPHENYL 2 4 DIAMINO 1 3 5 | authKW | 412644 | 1% | 100% | 1 |
6 | A ACITINOMYCETEMCOMITANS | authKW | 412644 | 1% | 100% | 1 |
7 | ACTINOBACILLUS ACTINOIMYCETEMCOMITANS | authKW | 412644 | 1% | 100% | 1 |
8 | CAMP DEPENDENT KINASE PKA | authKW | 412644 | 1% | 100% | 1 |
9 | CAS 84504 69 8 | authKW | 412644 | 1% | 100% | 1 |
10 | EMIL PROJECT CHUO KU | address | 412644 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 513 | 49% | 0% | 36 |
2 | Chemistry, Medicinal | 247 | 18% | 0% | 13 |
3 | Gastroenterology & Hepatology | 84 | 11% | 0% | 8 |
4 | Dentistry, Oral Surgery & Medicine | 46 | 7% | 0% | 5 |
5 | Cell Biology | 23 | 11% | 0% | 8 |
6 | Oncology | 22 | 11% | 0% | 8 |
7 | Microscopy | 10 | 1% | 0% | 1 |
8 | Medicine, Research & Experimental | 10 | 5% | 0% | 4 |
9 | Immunology | 8 | 7% | 0% | 5 |
10 | Biophysics | 5 | 4% | 0% | 3 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PERIODONTAL MED | 565249 | 14% | 14% | 10 |
2 | EMIL PROJECT CHUO KU | 412644 | 1% | 100% | 1 |
3 | FRONTIER MED SCIMINAMI KU | 157191 | 5% | 10% | 4 |
4 | PERIODONTOL MEDMINAMI KU | 137547 | 1% | 33% | 1 |
5 | STEL REGENERAT MED | 137547 | 1% | 33% | 1 |
6 | FRONTIER BIOMED SCI | 103160 | 1% | 25% | 1 |
7 | CHEMOTHER Y CHUO KU | 82527 | 1% | 20% | 1 |
8 | GASTROENTEROL NEPHROL K1 | 82527 | 1% | 20% | 1 |
9 | DENT MATSUDA | 68772 | 1% | 17% | 1 |
10 | PERIODONT MED | 68772 | 1% | 17% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DRUGS IN R&D | 11460 | 1% | 3% | 1 |
2 | GASTROENTEROLOGIA JAPONICA | 4340 | 3% | 1% | 2 |
3 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 3379 | 8% | 0% | 6 |
4 | JOURNAL OF PERIODONTAL RESEARCH | 2281 | 5% | 0% | 4 |
5 | JAPANESE JOURNAL OF PHARMACOLOGY | 1505 | 5% | 0% | 4 |
6 | MEDICAL MOLECULAR MORPHOLOGY | 1067 | 1% | 0% | 1 |
7 | JAPANESE JOURNAL OF CANCER RESEARCH | 1045 | 4% | 0% | 3 |
8 | MINERVA CHIRURGICA | 915 | 1% | 0% | 1 |
9 | JOURNAL OF PHARMACOLOGICAL SCIENCES | 707 | 3% | 0% | 2 |
10 | CHEMICAL & PHARMACEUTICAL BULLETIN | 379 | 5% | 0% | 4 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | NAKAMURA, A , TOUGOU, K , KITAZUMI, H , YAMADA, T , HONJOU, K , NONAKA, K , MUKAI, H , (2006) EFFECTS OF IRSOGLADINE ON P450-ISOFORM SPECIFIC ACTIVITIES IN HUMAN HEPATIC MICROSOMES.ARZNEIMITTELFORSCHUNG-DRUG RESEARCH. VOL. 56. ISSUE 7. P. 547-552 | 12 | 60% | 0 |
2 | HAYASHI, N , GEORGE, J , SHIROEDA, H , SAITO, T , TOSHIKUNI, N , TSUCHISHIMA, M , ARISAWA, T , TSUTSUMI, M , (2013) IRSOGLADINE MALEATE FOR THE TREATMENT OF RECURRENT APHTHOUS STOMATITIS IN HEPATITIS C VIRUS PATIENTS ON PEGYLATED-INTERFERON AND RIBAVIRIN: A PILOT STUDY.JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. VOL. 28. ISSUE 6. P. 1015-1018 | 9 | 60% | 0 |
3 | NOMURA, M , KAMATA, M , KOJIMA, H , HAYASHI, K , SAWADA, S , (2013) IRSOGLADINE MALEATE REDUCES THE INCIDENCE OF FLUOROURACIL-BASED CHEMOTHERAPY-INDUCED ORAL MUCOSITIS.ANNALS OF ONCOLOGY. VOL. 24. ISSUE 4. P. 1062-1066 | 7 | 44% | 10 |
4 | UCHIDA, Y , SHIBA, H , KOMATSUZAWA, H , HIRONO, C , ASHIKAGA, A , FUJITA, T , KAWAGUCHI, H , SUGAI, M , SHIBA, Y , KURIHARA, H , (2005) IRSOGLADINE MALEATE INFLUENCES THE RESPONSE OF GAP JUNCTIONAL INTERCELLULAR COMMUNICATION AND IL-8 OF HUMAN GINGIVAL EPITHELIAL CELLS FOLLOWING PERIODONTOPATHOGENIC BACTERIAL CHALLENGE.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. VOL. 333. ISSUE 2. P. 502-507 | 10 | 38% | 18 |
5 | MIYAGAWA, T , FUJITA, T , OUHARA, K , MATSUDA, S , KAJIYA, M , HAYASHIDA, K , IMAI, H , YOSHIMOTO, T , IWATA, T , SHIBA, H , ET AL (2013) IRSOGLADINE MALEATE REGULATES THE INFLAMMATORY RELATED GENES IN HUMAN GINGIVAL EPITHELIAL CELLS STIMULATED BY AGGREGATIBACTER ACTINOMYCETEMCOMITANS.INTERNATIONAL IMMUNOPHARMACOLOGY. VOL. 15. ISSUE 2. P. 340-347 | 12 | 26% | 2 |
6 | YAMAGUCHI, H , SUZUKI, K , NAGATA, M , KAWASE, T , SUKUMARAN, V , THANDAVARAYAN, RA , KAWAUCHI, Y , YOKOYAMA, J , TOMITA, M , KAWACHI, H , ET AL (2012) IRSOGLADINE MALEATE AMELIORATES INFLAMMATION AND FIBROSIS IN MICE WITH CHRONIC COLITIS INDUCED BY DEXTRAN SULFATE SODIUM.MEDICAL MOLECULAR MORPHOLOGY. VOL. 45. ISSUE 3. P. 140 -151 | 10 | 29% | 6 |
7 | AKAGI, M , AMAGASE, K , MURAKAMI, T , TAKEUCHI, K , (2013) IRSOGLADINE: OVERVIEW OF THE MECHANISMS OF MUCOSAL PROTECTIVE AND HEALING-PROMOTING ACTIONS IN THE GASTROINTESTINAL TRACT.CURRENT PHARMACEUTICAL DESIGN. VOL. 19. ISSUE 1. P. 106-114 | 11 | 22% | 10 |
8 | KAWANO, Y , IMAMURA, A , NAKAMURA, T , AKAISHI, M , SATOH, M , HANAWA, T , (2016) DEVELOPMENT AND CHARACTERIZATION OF ORAL SPRAY FOR STOMATITIS CONTAINING IRSOGLADINE MALEATE.CHEMICAL & PHARMACEUTICAL BULLETIN. VOL. 64. ISSUE 12. P. 1659 -1665 | 7 | 32% | 0 |
9 | MURAKAMI, K , OKIMOTO, T , KODAMA, M , TANAHASHI, J , MIZUKAMI, K , SHUTO, M , ABE, H , ARITA, T , FUJIOKA, T , (2011) COMPARISON OF THE EFFICACY OF IRSOGLADINE MALEATE AND FAMOTIDINE FOR THE HEALING OF GASTRIC ULCERS AFTER HELICOBACTER PYLORI ERADICATION THERAPY: A RANDOMIZED, CONTROLLED, PROSPECTIVE STUDY.SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. VOL. 46. ISSUE 3. P. 287 -292 | 7 | 33% | 6 |
10 | MIYAGAWA, T , FUJITA, T , YUMOTO, H , YOSHIMOTO, T , KAJIYA, M , OUHARA, K , MATSUDA, S , SHIBA, H , MATSUO, T , KURIHARA, H , (2016) AZITHROMYCIN RECOVERS REDUCTIONS IN BARRIER FUNCTION IN HUMAN GINGIVAL EPITHELIAL CELLS STIMULATED WITH TUMOR NECROSIS FACTOR-ALPHA.ARCHIVES OF ORAL BIOLOGY. VOL. 62. ISSUE . P. 64 -69 | 9 | 21% | 1 |
Classes with closest relation at Level 1 |